GE and Three Others Named Top Dividend Growers of Last Week
During the past week, GuruFocus recognized four companies as dividend growers. In order to be considered for this list, the company had to: A Have a dividend yield of more than 3%.
The Motley Fool
Abbott Loves Abbott Laboratories Stock
Abbott Laboratories seems to think its stock is cheap enough to justify sinking a substantial amount of its nest egg into the company's stock.
Market Report, "Abbott Japan Co., Ltd. - Pharmaceuticals & Healthcare ...
The company develops and sells nutritional, medical, diagnostic equipments and other products.
Fri Jun 14, 2013
Daily Dividend Report: ABT, LHO, DX, AT, RLJ
This afternoon, Abbott Laboratories declared its quarterly dividend of 14 cents per share, maintaining the amount paid to shareholders the last quarter.
Scooplet: Morris exiting Abbott - First in PI: Porterfield, Lowenthal ...
PI SCOOPLET ... MORRIS EXITING ABBOTT: Kristin Morris , divisional vice president of federal government affairs at Abbott Laboratories , is leaving for a new job.
Thu Jun 13, 2013
Identifying the Biggest Gem in Antares Pharma Inc (ATRS)'s Pipeline
ATRS ) 's transformational product , I have been inundated with reader requests to conduct a valuation study on another drug-device combination currently being advanced into QS-T is being developed to administer testosterone using a subcutaneous injection route by patients themselves, essentially eliminating the need to receive the doctor's office.
Wed Jun 12, 2013
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): These...
As populations grow and as food safety concerns increase, parents are being very selective about the infant baby formulas they buy.
Abbott Labs' Absorb And The Dissolvable Stent Race
In the first quarter of 2013 Abbott Laboratories' sales of medical devices fell 4.6% to $1.33 billion, with revenue from stents and related vascular products down almost 8% to $742 million due largely to price pressures in the United States.
Tue Jun 11, 2013
Sagent Advisors Expands Its Aerospace, Defense And Technology Practice
Sagent Advisors, LLC, a leading independent investment banking firm, announced today that Jeremy Parker has joined the firm as Managing Director, effective immediately.
Abbott Laboratories to Present at Research & Economics 2013 Healthcare Conference
An archived edition of the presentation will be available later that day. Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.
Mon Jun 10, 2013
The Washington Post
Abbott Doubled Niaspan U.S. Sales Before Bad Trials Cut Use
Abbott Laboratories aggressively promoted its Niaspan cholesterol treatment, almost tripling U.S. use of the medication, in the seven-year period before studies in 2011 found the drug ineffective, a study found.
Fri Jun 07, 2013
Wed Jun 05, 2013
AbbVie Pharmaceuticals - High Risk With Little Upside Potential
Abbott Laboratories is one of the major players in the American healthcare sector.
Cuccinelli says IRS is blocking $125M check to Virginia
Attorney General Kenneth T. Cuccinelli II said Wednesday that the Internal Revenue Service is blocking the release of $125 million owed to Virginia from a Medicaid fraud settlement.
Gleacher names Kearns as restructuring chief, CEO
Prior to co-founding Capstone, Kearns was a senior managing director at the Policano & Manzo legacy practice of FTI Consulting and a predecessor firm from 1991 to 2004.
Tue Jun 04, 2013
Abbott Laboratories to Present at 33rd Annual Growth Stock Conference
A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com .
The Washington Post
AstraZeneca Drops Development of Rigel Drug for Arthritis
AstraZeneca Plc will take a $140 million charge after deciding to halt development of an experimental rheumatoid arthritis treatment that showed mixed results in late-stage studies.
Mon Jun 03, 2013
MacReport Media RSS Feed
TNI BioTech, Inc. Announces Death of Senior Vice President and Chief ...
He was a visionary leader, a devoted father to his children, and a good friend. The company's directors and employees, as well as many of the people he worked with and mentored over the years, mourn his loss.
Fri May 31, 2013
The Motley Fool
Stocks to Buy: Value Biotechs
There are three types of biotech stocks to buy that generally fall into one of these typically non-overlapping groups: Value investing isn't usually associated with biotech stocks to buy; if anything, biotech investors are notorious for being overly optimistic.
Tue May 28, 2013
Abbott Laboratories Stock Rating Reaffirmed by Jefferies Group
's stock had its "buy" rating restated by research analysts at Jefferies Group in a report released on Tuesday, Analyst Ratings Network.com reports.